Compare peptides
Put two entries side by side — evidence, mechanism, risks, and community claims.
TB-500
Preclinical
Research chemical
Summary
Synthetic peptide related to thymosin beta-4, used in recovery communities for systemic tissue repair and flexibility.
Categories
Healing & Recovery, Performance
Mechanism
Thymosin beta-4 sequesters G-actin and influences cell motility, angiogenesis, and inflammation resolution in preclinical models. TB-500 is marketed as a more stable synthetic analog used to pursue similar recovery pathways.
Half-life
Longer than many short peptides; community protocols often use less frequent dosing
Routes
Subcutaneous injection; Intramuscular injection
Legal / access
Not approved as a drug for recovery or sports use. Restricted in sport and often sold for research only.
Key risks
- Lethargy or head pressure (anecdotal)
- Injection-site reactions
- Unknown long-term risks
Common claims
- Faster recovery from multi-site injuries
- Improved flexibility and reduced stiffness
- Systemic healing support alongside BPC-157
Select peptide B